MS:NYSEMorgan Stanley Analysis
Data as of 2026-09-06 - not real-time
$217.72
Latest Price
6/10Risk
Risk Level: Medium
Executive Summary
At $217.72, Morgan Stanley shows no decisive moving-average alignment, leaving the trend neutral. Across the trailing 30 sessions it gained 1.5%. Momentum indicators put RSI at 54.7 (neutral) with MACD reading bullish. The recent range runs from support at $207.32 up to resistance at $222.00.
The shares look fair, trading on 17.6 times earnings in line with a sector average of 16.5. The average analyst target implies 8.7% above today's level. Revenue is growing at 28.0% on a 25.9% profit margin. The 2.11% dividend yield looks covered by current payout levels.
Risk scores 6 out of 10, which is elevated for this asset class. With 30-day volatility of 26.3%, a beta of 1.38 and a maximum drawdown of 19.3%, position sizing matters here. The wider market backdrop reads extreme greed at 95 on the fear-greed composite.
Short, medium and long-term reads agree on buy, with conviction of 4/10.
The shares look fair, trading on 17.6 times earnings in line with a sector average of 16.5. The average analyst target implies 8.7% above today's level. Revenue is growing at 28.0% on a 25.9% profit margin. The 2.11% dividend yield looks covered by current payout levels.
Risk scores 6 out of 10, which is elevated for this asset class. With 30-day volatility of 26.3%, a beta of 1.38 and a maximum drawdown of 19.3%, position sizing matters here. The wider market backdrop reads extreme greed at 95 on the fear-greed composite.
Short, medium and long-term reads agree on buy, with conviction of 4/10.
Top Market Events
Morgan Stanley has lapped every major bank rival in 2026, but a rate spike just rattled the stock and the one price...
Market Outlook
Short Term
< 1 yearPositive
Model confidence: 5/10
Key Factors
- Trading above the 200-day average of 190.92
- MACD momentum is positive
- RSI at 54.7 is in neutral territory
Medium Term
1–3 yearsPositive
Model confidence: 4/10
Key Factors
- P/E of 17.6 versus sector average of 16.5
- Trading above the 200-day average of 190.92
- Analyst targets imply +8.7% versus the current price
Long Term
> 3 yearsPositive
Model confidence: 4/10
Key Factors
- P/E of 17.6 versus sector average of 16.5
- Analyst targets imply +8.7% versus the current price
- Profit margin of 25.9% is healthy
Key Metrics & Analysis
Financial Health
Revenue Growth28.00%
Profit Margin25.90%
P/E Ratio17.6
ROE17.97%
ROA1.34%
Debt/Equity517.28
P/B Ratio3.2
Op. Cash Flow$-15587000320
Industry P/E16.5
Technical Analysis
TrendNeutral
RSI54.7
Support$207.32
Resistance$222.00
MA 20$215.05
MA 50$215.59
MA 200$190.92
MACDBullish
VolumeStable
Fear & Greed Index95.48
Valuation
Target Price$236.62
Upside/Downside8.68%
GradeFair
TypeBlend
Dividend Yield2.11%
Risk Assessment
Beta1.38
Volatility26.34%
Sector RiskMedium
Reg. RiskHigh
Geo RiskLow
Currency RiskLow
Liquidity RiskLow
Similar Tickers
This analysis may contain inaccuracies and is provided for informational and research purposes only. It is not personal investment advice, a recommendation, or an instruction to buy, sell, or hold any asset.